| |
|
|
|
Xtalks, Online
2025-04-22
As drug safety teams face increasing regulatory demands and growing data volumes, leveraging artificial intelligence (AI)-driven tools has become essential for improving accuracy, efficiency and cost-effectiveness in pharmacovigilance.
In this webinar, the expert speakers will explore how AI can revolutionize drug safety case intake, transforming how case processing is managed.
Through a combination of real-world insights and expert perspectives, the expert speakers will cover:
A step-by-step walkthrough of how a case is processed—from email intake to AI-driven analysis, human review and database integration
A case study demonstrating the accuracy, speed and time-effectiveness of an AI tool compared to traditional methods
An exclusive interview with a subject matter expert (SME) who actively uses the tool, sharing their experience and feedback on its impact in daily operations
By the end of this webinar, attendees will have a comprehensive understanding of how an AI-powered solution can enhance drug safety workflows, drive better decision-making and enable quicker processing. Whether you are a pharmacovigilance professional, regulatory expert or data scientist in life sciences, this webinar will provide valuable insights into the future of AI-driven drug safety management.
Register for this webinar today to discover how AI-driven tools can revolutionize drug safety case intake and streamline pharmacovigilance workflows.
Keywords: Drug Development, Drug Discovery, Drug Safety, Pharmacovigilance, Regulatory, Regulatory Affairs, Regulatory Compliance, Artificial Intelligence, AI, Quality
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Asad Rashid, VP Safety and PV, Syneos Health
Heather Forster, Director, Safety and PV, Syneos Health
Jonathon Romero, PhD, Principal Safety & PV Ops Spec, Syneos Health
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2025-04-22
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|